Financial Contrast: biote (NASDAQ:BTMD) & MariMed (OTCMKTS:MRMD)

biote (NASDAQ:BTMDGet Rating) and MariMed (OTCMKTS:MRMDGet Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

Insider & Institutional Ownership

2.1% of biote shares are owned by institutional investors. Comparatively, 0.3% of MariMed shares are owned by institutional investors. 20.0% of MariMed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares biote and MariMed’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
biote N/A -52.44% 8.28%
MariMed 1.27% 4.02% 1.27%

Analyst Ratings

This is a breakdown of recent recommendations for biote and MariMed, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
biote 0 0 3 0 3.00
MariMed 0 0 2 0 3.00

biote currently has a consensus target price of $10.33, indicating a potential upside of 163.61%. Given biote’s higher probable upside, analysts plainly believe biote is more favorable than MariMed.

Risk and Volatility

biote has a beta of 0.48, indicating that its stock price is 52% less volatile than the S&P 500. Comparatively, MariMed has a beta of 3.35, indicating that its stock price is 235% more volatile than the S&P 500.

Earnings and Valuation

This table compares biote and MariMed’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
biote N/A N/A $11.11 million N/A N/A
MariMed $121.46 million 1.26 $7.22 million N/A N/A

biote has higher earnings, but lower revenue than MariMed.

About biote

(Get Rating)

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

About MariMed

(Get Rating)

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

Receive News & Ratings for biote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for biote and related companies with MarketBeat.com's FREE daily email newsletter.